USFDA Approval - Sun Pharmaceutical Industries Ltd

Code BSE: 524715 NSE:

Sun Pharma Announces FDA Approval of Next Generation BLU-U (registered) Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis The BLU-U Model 4170E offers a compact, easy-to-use option with the same BLU-U safety and efficacy. The new LED BLU-U is approved for the same indications as the previous model but takes up less space in a dermatologist’s office, and has a more flexible five-panel shape, improved LED arrangement, lighter weight, and other updated functions that may increase patient comfort and ease of use. “We are pleased to receive the FDA’s approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis,” said Abhay Gandhi, Sun Pharma North America CEO.